Home 2023

Companion diagnostics

Precede Biosciences Launches with Cell-Free Genomic Diagnostic for Drug Development and Precision Medicine
Cancer

Precede Biosciences Launches with Cell-Free Genomic Diagnostic for Drug Development and Precision Medicine

Jonathan D Grinstein, PhD -
0
Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics
Drug Discovery

Companion Diagnostics: Strategies for Effective Co-Development with Therapeutics

Melinda Kucsera -
0
Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation
Artificial Intelligence

Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation

Jonathan D Grinstein, PhD -
0
Merck to Acquire Prometheus Biosciences for $10.8B
Drug Discovery

Merck to Acquire Prometheus Biosciences for $10.8B

Alex Philippidis -
0
Biosimilars and Diversification Drive Innovation in mAb Manufacturing
Artificial Intelligence

Biosimilars and Diversification Drive Innovation in mAb Manufacturing

John Sterling -
0
GEN Protocols Expert Exchanges: COVID-19 Immunodiagnostic Test Identifies Antibody Source
Podcasts

GEN Protocols Expert Exchanges: COVID-19 Immunodiagnostic Test Identifies Antibody Source

GEN Staff Writer -
0
Agilent CEO Talks Diagnostics, Genomics, and 2022 Headwinds
Bioprocessing

Agilent CEO Talks Diagnostics, Genomics, and 2022 Headwinds

Alex Philippidis -
0
Advancing Liquid Biopsy Companion Diagnostics with a Novel Sequencing Initiative
Sponsored

Advancing Liquid Biopsy Companion Diagnostics with a Novel Sequencing Initiative

Kathy Vuksanaj -
0
NYC Doubles Life Sciences Bet to $1B
News

NYC Doubles Life Sciences Bet to $1B

Alex Philippidis -
0
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Cancer

Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership

Alex Philippidis -
0
123...12Page 1 of 12
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.